gammaCore
Acute Treatment of Migraine
Key Facts
About electroCore
electroCore is a commercial-stage therapeutics company focused on developing and commercializing its proprietary non-invasive vagus nerve stimulation (nVNS) platform, gammaCore. The company has achieved significant regulatory milestones, including FDA clearances for migraine and cluster headache, and is actively pursuing label expansion into new neurological and metabolic disorders. Its strategy centers on leveraging a reusable device platform and a robust IP portfolio to establish a leading position in the growing neuromodulation market.
View full company profileAbout electroCore
electroCore is a commercial-stage therapeutics company focused on developing and commercializing its proprietary non-invasive vagus nerve stimulation (nVNS) platform, gammaCore. The company has achieved significant regulatory milestones, including FDA clearances for migraine and cluster headache, and is actively pursuing label expansion into new neurological and metabolic disorders. Its strategy centers on leveraging a reusable device platform and a robust IP portfolio to establish a leading position in the growing neuromodulation market.
View full company profileAbout electroCore
electroCore is a commercial-stage therapeutics company focused on developing and commercializing its proprietary non-invasive vagus nerve stimulation (nVNS) platform, gammaCore. The company has achieved significant regulatory milestones, including FDA clearances for migraine and cluster headache, and is actively pursuing label expansion into new neurological and metabolic disorders. Its strategy centers on leveraging a reusable device platform and a robust IP portfolio to establish a leading position in the growing neuromodulation market.
View full company profileTherapeutic Areas
Other Acute Treatment of Migraine Drugs
| Drug | Company | Phase |
|---|---|---|
| Elismetrep (K-304) | Kallyope | Phase 2 |
| RizaFilm® (RizaPort®) | Gensco Pharma | Approved/Pre-launch |
| ONZETRA Xsail | Currax Pharmaceuticals | Approved |
| TREXIMET | Currax Pharmaceuticals | Approved |
| Nerivio | Theranica | Approved |
| NVI-100 | Nuvie Bio | Phase 1 |